251 286 - Biotech Bayern

IRIS BioTech GmbH
PHARMA & CHEMICAL INDUSTRY
Keywords: Drug Development, Drug Delivery, Fine Chemicals / Reagents,
Medicinal Chemistry, Combinatorial Chemistry, New Materials,
Natural Compounds
IRIS Biotech is specialized in reagents for Peptide Ssynthesis and products for
Life Science Research. We have specific know-how and production capabilities
to manufacture and supply products from the following areas from Grams to
Multi-Ton Lots: Starting Materials for Peptide Synthesis (Protected Amino Acids,
Coupling Reagents, Linkers and Resins). Reagents for PEGylation (monodisperse
and polydisperse; short (MW 300) to very long (MW 20.000) Glycol Spacers,
hydrophobic and amphiphilic SpacerMolecules; Contract Manufacturing of
PEG Spacers and PEGylation. Reagents for Life Science Research (Aflatoxines,
Cyclosporines, Cytochalasins, Geldanamycin, Methoxatin, Rapamycin, etc.)
Carbohydrates (Derivatives of Arabinose, Galactose, Glucose, Mannose, Xylose,
etc.) We are carrying out many Contract Manufacturing projects in these areas;
our strong points are unusual derivatives with one or several chiral centres.
We follow cGMP and ISO9000 and supply from typical lab scale for R&D to
multi-ton bulk quantities for production, in order to escort our customers'
projects during their evolution from R&D projects to commercial production.
Kendle GmbH
CRO
Keywords: Clinical Research, Monitoring, Allergy, Diabetics, Medical Writing,
Pharmacology, Oncology
Kendle International Inc. is a full-service, phase I - IV clinical development
organizsation. It contracts with pharmaceutical and biotechnology companies
to provide clinical testing and ancillary services necessary to get a new drug
or medical device approved by worldwide regulatory agencies. Kendle currently
employs more than 3,400 research professionals. Kendle provides services in
project planning and protocol development, clinical trials management and
monitoring, human pharmacology.
Please find more information about Kendle under http://www.kendle.com
KINAXO Biotechnologies GmbH
BIOTECH PRECLINICAL SERVICES
Keywords: Drug Development, Oncology, Genomics, Proteomics, Small Molecules,
Inflammation, Metabolic Diseases
KINAXO Biotechnologies GmbH is a spin-off from the Max Planck Institute of
Biochemistry in Martinsried. We offer a comprehensive chemical-proteomics
technology – known as KinaTor – to identify and characterise the interaction
of small molecule inhibitors with their protein targets in the physiological
context of a cell. Tailored to protein kinases, the KinaTor technology represents a
highly efficient approach to developing selective kinase inhibitors for targeted
therapies.
Contact:
Waldershofer Str. 49-51
D-95615 Marktredwitz
Phone: +49 (0) 9231 9619-73
Fax: +49 (0) 9231 9619-99
Internet: www.iris-biotech.de
Contact:
Dr. Dieter Seitz-Tutter
Stefan-George-Ring 6
D-81929 München
Phone: +49 (0) 89 99 39 13-565
Fax: +49 (0) 89 99 39 13-429
E-Mail: luckner.andrea@kendle.com
Internet: www.kendle.com
Contact:
Dr. Andreas Jenne
Am Klopferspitz 19a
D-82152 Martinsried/München
Phone: +49 (0) 89 700763-831
Fax: +49 (0) 89 700763-833
E-Mail: info@kinaxo.com
Internet: www.kinaxo.de
77